| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700896 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
Preoperatively increased GPS is significantly associated with reduced postoperative survival and tumor recurrence. The GPS as an independent prognosticator should be interpreted together with the TNM stage when the further postoperative treatment has to be scheduled.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Lindenmann, N. Fink-Neuboeck, A. Avian, M. Pichler, M. Habitzruther, A. Maier, F.M. Smolle-Juettner,